ELEVANCE HEALTH, INC. (ELV) FY2026 Q1 Balance Sheet

ELEVANCE HEALTH, INC. (ELV) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets

125,827,000,000 US dollars

Current assets

67,032,000,000 US dollars

Non-current assets

58,795,000,000 US dollars

Liabilities

81,785,000,000 US dollars

Current liabilities

45,309,000,000 US dollars

Non-current liabilities

36,476,000,000 US dollars

Equity

44,042,000,000 US dollars

Noncontrolling interest

140,000,000 US dollars. Included in consolidated equity; this amount is not added again.

Fixed maturity securities (amortized cost of $26,177 and $25,773; allowance for credit losses of $55 and $21)

25,905,000,000 US dollars

Premium receivables, net

11,525,000,000 US dollars

Cash and cash equivalents

9,657,000,000 US dollars

Other current assets

7,169,000,000 US dollars

Other receivables

6,167,000,000 US dollars

Self-funded receivables, net

5,098,000,000 US dollars

Equity securities

1,511,000,000 US dollars

Goodwill

28,340,000,000 US dollars

Other intangible assets

11,093,000,000 US dollars

Other invested assets

11,009,000,000 US dollars

Property and equipment, net

4,657,000,000 US dollars

Other noncurrent assets

2,582,000,000 US dollars

Fixed maturity securities (amortized cost of $1,121 and $1,116; allowance for credit losses of $$0 and $0)

1,114,000,000 US dollars

Medical claims payable

18,425,000,000 US dollars

Other current liabilities

13,985,000,000 US dollars

Accounts payable and accrued expenses

6,209,000,000 US dollars

Other policyholder liabilities

3,857,000,000 US dollars

Unearned income

1,759,000,000 US dollars

Short-term borrowings

724,000,000 US dollars

Current portion of long-term debt

350,000,000 US dollars

Long-term debt, less current portion

30,768,000,000 US dollars

Other noncurrent liabilities

3,922,000,000 US dollars

Deferred tax liabilities, net

1,786,000,000 US dollars

Retained earnings

35,796,000,000 US dollars

Additional paid-in capital

8,845,000,000 US dollars

Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 217,368,494 and 220,723,898

2,000,000 US dollars

Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none

0 US dollars

Noncontrolling interests

140,000,000 US dollars

Accumulated other comprehensive loss

negative 741,000,000 US dollars

Gross equity (calculated)

44,783,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.